These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18958746)

  • 41. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.
    Salliot C; Finckh A; Katchamart W; Lu Y; Sun Y; Bombardier C; Keystone E
    Ann Rheum Dis; 2011 Feb; 70(2):266-71. PubMed ID: 21097801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autologous stem cell transplantation in autoimmune diseases.
    Passweg J; Tyndall A
    Semin Hematol; 2007 Oct; 44(4):278-85. PubMed ID: 17961728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the B cell in rheumatoid arthritis.
    Cohen SB
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):553-63. PubMed ID: 20732652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.
    Van Laar JM; Tyndall A
    Cancer Control; 2003; 10(1):57-65. PubMed ID: 12598856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rituximab in hematopoietic cell transplantation.
    Arai S; Miklos DB
    Expert Opin Biol Ther; 2010 Jun; 10(6):971-82. PubMed ID: 20420511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The status of stem cell transplantation for rheumatoid arthritis: a rheumatologist's view.
    Furst DE
    J Rheumatol Suppl; 2001 Oct; 64():60-1. PubMed ID: 11642508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J; Wun T; Schmidt S; Naguwa SM; Tuscano JM
    J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic transplantation for Hodgkin's lymphoma.
    Corradini P; Sarina B; Farina L
    Br J Haematol; 2011 Feb; 152(3):261-72. PubMed ID: 21155760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Stem cell transplantation in patients with low-grade non-Hodgkin lymphoma].
    Mandigers CM; Schattenberg AV; Raemaekers JM
    Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2045-8. PubMed ID: 11072506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Autologous versus allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia].
    Wang GR; Xu Y; Zou DH; Zhao YZ; Wang M; Han MZ; Feng SZ; Yan WW; Qiu LG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):544-8. PubMed ID: 16995310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cells in the aetiopathogenesis and therapy of rheumatic disease.
    Moore J; Tyndall A; Brooks P
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):711-26. PubMed ID: 11812017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.
    Cohen Y; Polliack A; Nagler A
    Curr Pharm Des; 2003; 9(3):279-88. PubMed ID: 12570832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Achievement in therapy for rheumatoid arthritis without dysfunctional sequela].
    Takeuchi T
    Clin Calcium; 2012 Feb; 22(2):167. PubMed ID: 22737767
    [No Abstract]   [Full Text] [Related]  

  • 58. Autologous blood stem cell transplantation as therapy for autoimmune diseases.
    Bingham SJ; Snowden JA; Emery P
    Ann Med; 2000 Dec; 32(9):615-21. PubMed ID: 11209969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis?
    Lowenthal RM; Graham SR
    J Clin Immunol; 2000 Jan; 20(1):17-23. PubMed ID: 10798603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive surgery.
    Espigado I; García A; Rodríguez JM; Valenzuela A; Marín-Niebla A; Carmona M
    Clin Exp Rheumatol; 2003; 21(5):643-4. PubMed ID: 14611116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.